Appointment booking for Dr. Alexis Argoudelis, MD is currently not available.Dr. Alexis Argoudelis, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Alexis Argoudelis, MD (he/him) is a Nephrologist in Saint Louis, MO with over 18 years of experience. What is your opinion of Dr. Alexis Argoudelis, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Alexis Argoudelis, MD has received over $1,442 which includes payments from the following companies:
$371.80 from Bard Peripheral Vascular, Inc.
$290.57 from Covidien LP
$146.54 from Mallinckrodt LLC
$135.72 from Otsuka America Pharmaceutical, Inc.
$92.27 from Relypsa, Inc.
$86.97 from Amgen Inc.
$52.10 from Keryx Biopharmaceuticals, Inc.
$46.23 from OPKO Pharmaceuticals, LLC
$40.11 from Genentech USA, Inc.
$31.85 from AstraZeneca Pharmaceuticals LP
$27.73 from Takeda Pharmaceuticals U.S.A., Inc.
$24.99 from Shire North American Group Inc
$23.57 from Cumberland Pharmaceuticals, Inc.
$23.31 from Maquet Cardiovascular U.S. Sales, L.L.C.
$18.72 from Fresenius USA Marketing, Inc.
$14.78 from Luitpold Pharmaceuticals Inc
$14.77 from AbbVie, Inc.
Payments received by Dr. Alexis Argoudelis, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!